GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Euroespes SA (XMAD:EEP) » Definitions » Debt-to-Revenue

Euroespes (XMAD:EEP) Debt-to-Revenue : 1.33 (As of Dec. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Euroespes Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Euroespes's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €1.77 Mil. Euroespes's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €2.60 Mil. Euroespes's annualized Revenue for the quarter that ended in Dec. 2022 was €3.28 Mil. Euroespes's annualized Debt-to-Revenue for the quarter that ended in Dec. 2022 was 1.33.


Euroespes Debt-to-Revenue Historical Data

The historical data trend for Euroespes's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroespes Debt-to-Revenue Chart

Euroespes Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.31 1.40 1.45 1.21 1.32

Euroespes Semi-Annual Data
Dec12 Jun13 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.54 1.05 1.40 1.33

Competitive Comparison of Euroespes's Debt-to-Revenue

For the Diagnostics & Research subindustry, Euroespes's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euroespes's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Euroespes's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Euroespes's Debt-to-Revenue falls into.



Euroespes Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Euroespes's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.768 + 2.597) / 3.298
=1.32

Euroespes's annualized Debt-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.768 + 2.597) / 3.28
=1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2022) Revenue data.


Euroespes Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Euroespes's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroespes (XMAD:EEP) Business Description

Traded in Other Exchanges
N/A
Address
Santa Marta de Babio, Bergondo, La Coruna, ESP, 15165
Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.